Gaudium IVF Board Meeting on Aug 13 to Approve Q1 FY27 Unaudited Results

Gaudium IVF and Women Health Ltd has announced that its Board of Directors will convene on August 13, 2026. The primary agenda item is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The meeting will also take on record the Auditor's Limited Review Report. The company has also informed about the closure of the trading window for designated persons from July 1, 2026, until 48 hours after the results declaration, in compliance with SEBI Insider Trading Regulations. The disclosure will be hosted on the company's website.